VEENENDAAL, The Netherlands, November 24 /PRNewswire/ -- Nucletron BV and Siemens Medical Solutions announce a worldwide distribution agreement for Oncentra MasterPlan. This agreement will provide Siemens customers with access to the most advanced treatment planning solution in the market today, directly through Siemens sales organization.
“We are very excited about being able to offer the Oncentra MasterPlan software to a larger customer base, through our distribution agreement with Siemens OCS,” states David Imperiali, Managing Director of Nucletron BV. “A key element of our strategy is to develop software solutions which are clinically relevant regardless of the hospital’s choice of equipment; we are delighted to have the endorsement of one of the leading equipment providers”.
Ajit Singh, President of Siemens Oncology Care Systems, states “Oncentra MasterPlan is one of the most advanced treatment-planning system on the market today. A suite of individual treatment-planning modules for external-beam radiotherapy, Oncentra MasterPlan has been designed with DICOM integration, connectivity and flexibility in mind. Oncentra MasterPlan is available in all countries worldwide, and Siemens will distribute MasterPlan on a non-exclusive basis”.
About Oncentra MasterPlan
Oncentra MasterPlan is part of Nucletron’s family of Oncentra software solutions for oncology. Oncentra MasterPlan integrates completely into the Oncentra Information Management solution.
MasterPlan consists of four modules. Oncentra Anatomy uses best-in-class tools for sophisticated contouring, segmentation and multi-modality image registration and fusion. Oncentra Virtual Simulation provides high-quality image manipulation and advanced contouring tools, easy beam set-up and real-time generated DRRs. Oncentra Optimizer gives users rapid optimization through an extremely advanced algorithm. Oncentra Evaluation allows interactive dose shaping for 3D plan evaluation and generates Dose Volume Histograms.
About Siemens Medical Solutions
Siemens Medical Solutions of Siemens AG with headquarters in Malvern, Pennsylvania and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Employing approximately 31,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.6 billion EUR, orders of 8.6 billion EUR and group profit of 976 million EUR for fiscal 2005 (preliminary figures). More information can be obtained by visiting http://www.usa.siemens.com/medical-pressroom.
About Nucletron B.V.
Nucletron is a global leader in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in treatment planning systems, brachytherapy, simulation, integrated software solutions for oncology, and comprehensive support and professional education and services. The company has over 20 offices worldwide, including its corporate headquarters in Veenendaal, the Netherlands. For more information on Nucletron, please visit: www.nucletron.com.
Nucletron B.V. is a subsidiary of Delft Instruments. Delft Instruments is the holding company of an international group of companies, which hold a leading position in their respective markets with high quality, high technology products and services. Delft Instruments is active through wholly owned subsidiaries in more than 30 countries worldwide, employs approximately 1,000 people and reported turnover of EUR 261.6 million in 2004. For more information on Delft Instruments, please visit: www.delftinstruments.com.
Nucletron B.V
CONTACT: For further information: Mark Adam, General Manager & V.P.Marketing, Nucletron B.V., Phone: +31-318-557-149, E-mail:mark.adam@nl.nucletron.com or Paul van den Biggelaar, Director OncentraSoftware, Nucletron B.V., Phone: +31-318-557-221, E-mail:paul.vandenbiggelaar@nl.nucletron.com
